Skip to main content
. 2024 Jul 2;28(5):575–591. doi: 10.1007/s40291-024-00722-0
Gene therapy development for inherited retinal disease is a highly active area of research.
Delivery of gene therapies to the retina is well tolerated across multiple human trials.
Completed trials can guide future trial planning with a better understandining of appropriate endpoints.